Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 2770 Carcinoma, Non-Small-Cell Lung 2267 Prostatic Neoplasms 1430 Colorectal Neoplasms 1296 Neoplasms 1262 Multiple Myeloma 1086 Lung Neoplasms 1050 Neoplasm Metastasis 996 Leukemia, Myeloid, Acute 985 Lymphoma 900 Melanoma 864 Pancreatic Neoplasms 820 Ovarian Neoplasms 808 Carcinoma, Hepatocellular 783 Stomach Neoplasms 754 Recurrence 752 Leukemia 733 Lymphoma, Non-Hodgkin 685 Leukemia, Lymphocytic, Chronic, B-Cell 665 Squamous Cell Carcinoma of Head and Neck 618 Lymphoma, Large B-Cell, Diffuse 617 Precursor Cell Lymphoblastic Leukemia-Lymphoma 605 Head and Neck Neoplasms 601 Brain Neoplasms 593 Carcinoma, Renal Cell 587 Glioblastoma 573 Rectal Neoplasms 565 Sarcoma 523 Myelodysplastic Syndromes 522 Lymphoma, Follicular 516

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Interventional × Advanced Kidney Cancer × Clear all

NCT05485883 2022-08-08

TILUR

Tianjin Medical University Second Hospital

Phase 2 Unknown

Advanced Kidney Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡